{
    "clinical_study": {
        "@rank": "40317", 
        "arm_group": [
            {
                "arm_group_label": "MealShape cinnamon extract", 
                "arm_group_type": "Experimental", 
                "description": "Intake of 2 capsules of 500 mg MealShape 30 minutes before consumption of a standard meal (white bread)"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Intake of 2 capsules of 500 mg placebo, composed of 20% microcrystalline cellulose and 80% dicalcium phosphate, 30 minutes before consumption of a standard meal (white bread)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate the effect of MealShape, a Ceylon cinnamon extract\n      (Cinnamomum zeylanicum) on blood glucose and insulin response after consumption of a\n      standard meal composed of white bread, in healthy male and female volunteers."
        }, 
        "brief_title": "A Human Clinical Trial Evaluating the Effect of MealShape\u2122 on Blood Glucose Level Following Consumption of Standard Meal", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Postprandial Glycemia", 
            "Postprandial Insulinemia"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male and female volunteers, able to read and write, aged from 18 to 45 years\n             inclusive at time of screening\n\n          -  Good physical condition\n\n          -  Body Mass Index (BMI) \u2265 18,5 and < 25 kg/m\u00b2\n\n          -  Written informed consent provided prior to screening, after receiving and\n             understanding the subject information\n\n          -  Stable body weight (< 5% variation) within the last 3 months prior to screening.\n\n          -  Subject accepting to keep the same lifestyle throughout the study regarding physical\n             activity, no smoking etc.\n\n          -  Registered with the French Social Security, in agreement with the French law on\n             biomedical experimentation.\n\n        Exclusion Criteria:\n\n          -  Subject with type 1 or 2 diabetes\n\n          -  Smoker. Light smoker (less than 5 cigarettes per day) or former smoker (smoking more\n             than 5 cigarettes per day) having stopped less than three months. Smoking (or use of\n             smoking substitute e.g. nicotine patch) is not permitted from screening throughout\n             the study.\n\n          -  Subject with fasting capillary blood glucose level > 110 mg/dl.\n\n          -  Subject with fasting capillary blood glucose level \u2264 110 mg/dl and 2 hours\n             postprandial capillary blood glucose level > 140 mg/dl during an Oral Glucose\n             Tolerance Test.\n\n          -  Subject with any sensitivity or allergy to any of the products used within this\n             clinical trial.\n\n          -  Intake of product (food and dietary supplement) having an effect on glycemia and\n             insulinemia.\n\n          -  Intake of all chronic medication excepted oestroprogestative or progestative\n             contraception started at least three months preceding the screening visit."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02074423", 
            "org_study_id": "12-026"
        }, 
        "intervention": [
            {
                "arm_group_label": "MealShape cinnamon extract", 
                "description": "Acute administration of 1 g PO (2 capsules of 500 mg)", 
                "intervention_name": "MealShape cinnamon extract", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Acute administration of 1 g PO (2 capsules of 500 mg)", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cinnamon extract", 
            "Postprandial glycemia", 
            "Glycemic index", 
            "Pre-diabetes", 
            "Metabolic syndrome"
        ], 
        "lastchanged_date": "February 26, 2014", 
        "link": [
            {
                "description": "Guidance on the scientific requirements for health claims related to 2 appetite ratings, weight management, and blood glucose concentrations", 
                "url": "http://www.efsa.europa.eu/fr/efsajournal/doc/2604.pdf"
            }, 
            {
                "description": "International Diabetes Federation: Guideline for management of postmeal glucose (2007)", 
                "url": "http://www.idf.org/webdata/docs/Guideline_PMG_final.pdf"
            }, 
            {
                "description": "World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia : report of a WHO/IDF consultation", 
                "url": "http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Lilles", 
                    "country": "France", 
                    "zip": "59020"
                }, 
                "name": "Centre de Nutrition Clinique Naturalpha"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Controlled, Double-blind, Cross-over Clinical Trial, Evaluating the Effect of MealShape\u2122 on the Postprandial Glycemia After Eating Standard Food, in Healthy Volunteers.", 
        "overall_official": {
            "affiliation": "NATURALPHA", 
            "last_name": "Xavier Deplanque", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Blood glucose incremental Area Under the Curve between 0 and 120 minutes after consumption of a standard meal, compared between MealShape and the placebo", 
            "safety_issue": "No", 
            "time_frame": "Over 120 minutes after the consumption of a standard meal"
        }, 
        "reference": [
            {
                "PMID": "11742409", 
                "citation": "Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001 Dec 13;414(6865):782-7. Review."
            }, 
            {
                "PMID": "22608371", 
                "citation": "Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, Dietz W. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012 Jun;42(6):563-70. doi: 10.1016/j.amepre.2011.10.026."
            }, 
            {
                "PMID": "22093965", 
                "citation": "Rafehi H, Ververis K, Karagiannis TC. Controversies surrounding the clinical potential of cinnamon for the management of diabetes. Diabetes Obes Metab. 2012 Jun;14(6):493-9. doi: 10.1111/j.1463-1326.2011.01538.x. Epub 2011 Dec 27. Review."
            }, 
            {
                "PMID": "21480806", 
                "citation": "Davis PA, Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food. 2011 Sep;14(9):884-9. doi: 10.1089/jmf.2010.0180. Epub 2011 Apr 11. Review."
            }, 
            {
                "PMID": "17909085", 
                "citation": "Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2008 Jan;31(1):41-3. Epub 2007 Oct 1."
            }, 
            {
                "PMID": "23102179", 
                "citation": "Magistrelli A, Chezem JC. Effect of ground cinnamon on postprandial blood glucose concentration in normal-weight and obese adults. J Acad Nutr Diet. 2012 Nov;112(11):1806-9. doi: 10.1016/j.jand.2012.07.037."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02074423"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Blood glucose incremental Area Under the Curve between 0 and 60 minutes  compared between MealShape and the placebo after consumption of a standard meal,", 
                "safety_issue": "No", 
                "time_frame": "Over 60 minutes after consumption of a standard meal"
            }, 
            {
                "measure": "Capillary blood glucose maximal concentration between MealShape and Placebo after consumption of a standard meal", 
                "safety_issue": "No", 
                "time_frame": "Over 120 minutes after consumption of a standard meal"
            }, 
            {
                "measure": "Comparison of glycemia values between MealShape and Placebo at the following time points: T0, T15, T30, T45, T60, T90 and T120 minutes after consumption of a standard meal", 
                "safety_issue": "No", 
                "time_frame": "Over 120 minutes after consumption of a standard meal"
            }, 
            {
                "measure": "Evaluation of the safety of MealShape with adverse events recording", 
                "safety_issue": "Yes", 
                "time_frame": "3 weeks"
            }, 
            {
                "measure": "Insulin incremental Area under the Curve between 0 and 120 minutes compared between MealShape and Placebo after consumption of a standard meal", 
                "safety_issue": "No", 
                "time_frame": "Over 120 minutes after consumption of a standard meal"
            }, 
            {
                "measure": "Insulin incremental Area under the Curve between 0 and 60 minutes compared between MealShape and Placebo after consumption of a standard meal", 
                "safety_issue": "No", 
                "time_frame": "Over 60 minutes after connsumption of a standard meal"
            }
        ], 
        "source": "Dialpha", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dialpha", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}